Nitro-Time (nitroglycerin) NDC 49483-221

NDC codes

FDA NDC Directory

Product NDC (as listed)49483-221Labeler and product segments. Claims need a package NDC.

Product NDC at billing width49483-0221Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
49483-221-06	49483022106	60 CAPSULE in 1 BOTTLE, PLASTIC (49483-221-06)Marketed from Oct 9, 2018
49483-221-10	49483022110	100 CAPSULE in 1 BOTTLE, PLASTIC (49483-221-10)Marketed from Oct 9, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Nitro-Time
Generic name (nonproprietary): nitroglycerin
Active ingredients: Nitroglycerin — 2.5 mg/1
Dosage form: Capsule
Route: Oral
Labeler: TIME CAP LABORATORIES, INC
Product type: Prescription drug
Marketing category: Unapproved drug (other)
Marketing start: Jun 19, 2014
Listing expires: Dec 31, 2027
Other FDA classes: Nitrates (Chemical structure)Vasodilation (Physiologic effect)
Identifiers: Product ID 49483-221_51ed5c69-89ac-27ed-e063-6394a90acca1SPL ID 51ed5c69-89ac-27ed-e063-6394a90acca1SPL set ID 3c11c1c2-8e62-4f63-8293-2f8b8d845f7eRxCUI 312013, 312018, 312020UNII G59M7S0WS3UPC 0349483221107, 0349483223101, 0349483222067
Pharmacologic class: Nitrate Vasodilator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N449483022106 followed by a unit qualifier and the quantity

Package 49483-0221-06. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 18, 2026.

Indications (excerpt from the label)

INDICATIONS AND USAGE: Nitroglycerin Extended-Release Capsules are indicated for the prevention of angina pectoris due to coronary artery disease. The onset of action of oral nitroglycerin is not sufficiently rapid for this product to be useful in aborting an acute anginal episode.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)